A major international study has concluded that diet, rather than insufficient physical activity, is the leading cause of rising obesity rates in developed countries.

People coming off powerful weight-loss drugs such as Wegovy and Mounjaro should receive at least a year of follow-up care to prevent regaining the weight they’ve lost, new NHS guidance recommends.

A large proportion of children referred to NHS excess weight clinics in England are from the most deprived areas, and many are also living with neurodivergence or other serious health conditions, new research has revealed.

A daily pill for obesity could help people lose around twelve per cent of their body weight over a seventy-two-week period, according to trial results.

Eli Lilly and Company and the UK Government Department for Science, Innovation and Technology (DSIT) have announced a programme to develop innovative models of care for obesity.

Pakistan is facing a severe obesity epidemic, with 81 per cent of women and 74 per cent of men now classified as obese, health experts revealed at a seminar in Lahore.

New research from Germany has found that eating most of your daily calories later in the day may negatively affect metabolism and increase the risk of obesity and type 2 diabetes.

Patients taking weight loss drugs such as Ozempic and Wegovy may begin to regain weight within weeks of stopping the medication, a new study has found.

A new study has found that GLP-1 receptor agonists offer clear advantages over traditional treatments for idiopathic intracranial hypertension (IIH), with fewer headaches, visual symptoms and reduced need for medication or surgery.

Medications that target glucagon-like peptide-1 (GLP-1) could significantly improve testosterone levels and overall health outcomes in men and women diagnosed with obesity or type 2 diabetes (T2D), according to new research presented at the Endocrine Society’s 2025 annual meeting.

An international study has found that a child’s genetic profile could accurately predict their future risk of living with obesity. Researchers say the findings could pave the way for earlier and more targeted prevention efforts – long before weight-related health issues take hold.

Dozens of people living with obesity across England have reported experiencing stigmatising and inappropriate comments from NHS doctors, according to new data.

A recent US study has shown how a sharp rise in obesity has driven a threefold increase in deaths from cancers linked to excess weight.

New research suggests that weight loss injections such as Wegovy and Mounjaro may offer protective benefits against dementia, stroke and premature death in people living with type 2 diabetes and obesity.

Leading UK experts are calling for tighter regulation of weight loss surgery abroad, warning that the booming trade in bariatric medical tourism is placing lives at risk.

Obesity is a known risk factor for stroke, but using body mass index (BMI) alone to assess stroke risk may not be enough. A new international study suggests that better predictors are available — and artificial intelligence could help improve early detection and prevention.

At the recent Blackburn Course in Obesity Medicine, hosted by Harvard Medical School, Dr Harold Bays, Medical Director at the Louisville Metabolic and Atherosclerosis Research Center, highlighted the direct and indirect ways in which obesity increases the risk of cardiovascular disease.

A new study has found that one in five adults living with overweight in the United States could be newly classified as living with obesity under a revised definition developed by the European Association for the Study of Obesity (EASO).

The true cost of the UK’s overweight and obesity crisis has reached an eye-watering £126 billion a year, according to a major new analysis by Frontier Economics for the Nesta think tank.

Childhood obesity has reached "alarming" levels in the UK, prompting leading scientists to call for urgent action to establish healthy habits during the earliest stages of life.